Timing of antibiotic administration and outcomes of hospitalized patients with community-acquired and healthcare-associated pneumonia

Clinical Microbiology and Infection

Volumn 18, Issue 11, 2012, Pages 1149-1155

  Simonetti, A ^a   Viasus, D ^a   Garcia Vidal, C ^a   Adamuz, J ^a   Roset, A ^a   Manresa, F ^a,b   Dorca, J ^a,b   Gudiol, F ^a,b   Carratala J ^a,b  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Antibiotic timing; Community acquired pneumonia; Healthcare associated pneumonia; Mortality; Risk factors

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFTRIAXONE; LEVOFLOXACIN; MACROLIDE;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DRUG EFFECT; EMERGENCY WARD; FEMALE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; THERAPY DELAY;

EID: 84867694090     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2011.03709.x     Document Type: Article

References (33)

1. Garau J, Calbo E. Community-acquired pneumonia. Lancet 2008; 371: 455-458.
2. Arnold FW, LaJoie AS, Brock GN et al. Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: Community-Acquired Pneumonia Organization International cohort study results. Arch Intern Med 2009; 169: 1515-1524.
3. Johnstone J, Eurich DT, Minhas JK, Marrie TJ, Majumdar SR. Impact of the pneumococcal vaccine on long-term morbidity and mortality of adults at high risk for pneumonia. Clin Infect Dis 2010; 51: 15-22.
4. Carratalà J, Fernández-Sabé N, Ortega L et al. Outpatient care compared with hospitalization for community-acquired pneumonia: a randomized trial in low-risk patients. Ann Intern Med 2005; 142: 165-172.
5. Fine MJ, Auble TE, Yealy DM et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336: 243-250.
6. Mandell LA, Wunderink RG, Anzueto A et al. IDSA/ATS consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44 (suppl 2): S27-S72.
7. Austrian R, Gold J. Pneumococcal bacteremia with special reference to bacteremic pneumococcal pneumonia. Ann Intern Med 1964; 60: 759-770.
8. Pines JM. Timing of antibiotics for acute, severe infections. Emerg Med Clin North Am 2008; 26: 245-257.
9. Welker JA, Huston M, McCue JD. Antibiotic timing and errors in diagnosing pneumonia. Arch Intern Med 2008; 168: 351-356.
10. Battleman DS, Callahan M, Thaler HT. Rapid antibiotic delivery and appropriate antibiotic selection reduce length of hospital stay of patients with community-acquired pneumonia: link between quality of care and resource utilization. Arch Intern Med 2002; 162: 682-688.
11. Silber SH, Garrett C, Singh R et al. Early administration of antibiotics does not shorten time to clinical stability in patients with moderate-to-severe community-acquired pneumonia. Chest 2003; 124: 1798-1804.
12. Waterer GW, Kessler LA, Wunderink RG. Delayed administration of antibiotics and atypical presentation in community-acquired pneumonia. Chest 2006; 130: 11-15.
13. Meehan TP, Fine MJ, Krumholz HM et al. Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA 1997; 278: 2080-2084.
14. Cheng AC, Buising KL. Delayed administration of antibiotics and mortality in patients with community-acquired pneumonia. Ann Emerg Med 2009; 53: 618-624.
15. Houck PM, Bratzler DW, Nsa W, Ma A, Bartlett JG. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med 2004; 164: 637-644.
16. Metersky ML, Sweeney TA, Getzow MB, Siddiqui F, Nsa W, Bratzler DW. Antibiotic timing and diagnostic uncertainty in Medicare patients with pneumonia. Is it reasonable to expect all patients to receive antibiotics within 4hours. Chest 2006; 130: 16-21.
17. Kanwar M, Brar N, Khatib R, Fakih MG. Misdiagnosis of community-acquired pneumonia and inappropriate utilizations of antibiotics: side effects of the 4-hour antibiotic administration rule. Chest 2007; 131: 1865-1869.
18. Yu KT, Wyer PC. Evidence behind the 4-hour rule for initiation of antibiotic therapy in community-acquired pneumonia. Ann Emerg Med 2008; 51: 651-662.
19. Bruns AH, Oosterheert JJ, Hustinx WN et al. Time for first antibiotic dose is not predictive for the early clinical failure of moderate-severe community-acquired pneumonia. Eur J Clin Microbiol Infect Dis 2009; 28: 913-919.
20. Pines JM, Isserman JA, Hinfey PB. The measurement of time to first antibiotic dose for pneumonia in the emergency department: a white paper and position statement prepared for the American Academy of Emergency Medicine. J Emerg Med 2009; 37: 335-340.
21. Mandell LA, Bartlett JG, Dowell SF et al. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis 2003;37:1405-1433.
22. Lim WS, Baudouin SV, George RC et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009; 64 (suppl 3): iii1-iii55.
23. Carratalà J, Mykietiuk A, Fernández-Sabé N et al. Health care-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes. Arch Intern Med 2007; 167: 1393-1399.
24. Kollef MH, Shorr A, Tabak YP, Gupta V, Liu LZ, Johannes RS. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US data-base of culture-positive pneumonia. Chest 2005; 128: 3854-3862.
25. Micek ST, Kollef KE, Reichley RM, Roubinian N, Kollef MH. Healthcare-associated pneumonia and community-acquired pneumonia: a single-center experience. Antimicrob Agents Chemother 2007; 51: 3568-3573.
26. Shindo Y, Sato S, Maruyama E et al. Health-care associated pneumonia among hospitalized patients in a Japanese community hospital. Chest 2009; 135: 633-640.
27. American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171: 388-416.
28. Abrahamian FM, Deblieux PM, Emerman CL et al. Health care-associated pneumonia: identification and initial management in the ED. Am J Emerg Med 2008; 6 (suppl): 1-11.
29. Bone RC, Balk RA, Cerra FB et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101: 1644-1655.
30. Garcia-Vidal C, Viasus D, Roset A. Low incidence of multidrug-resistant organisms in patients with healthcare-associated pneumonia requiring hospitalization. Clin Microbiol Infect 2011; 17: 1659-1665.
31. Vittinghoff E, McCulloch CE. Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol 2007; 165: 710-718.
32. Dedier J, Singer DE, Chang Y, Moore M, Atlas SJ. Processes of care, illness severity, and outcomes in the management of community-acquired pneumonia at academic hospitals. Arch Intern Med 2001; 161: 2099-2104.
33. Attridge RT, Frei CR, Restrepo MI et al. Guideline-concordant therapy and outcomes in healthcare-associated pneumonia. Eur Respir J 2011; 38: 878-887.